Apimeds Pharmaceuticals US, Inc. clarified on April 9, 2026, that a Stockholder Consent to remove directors and officers from March 20, 2026, is invalid due to violations of a Support Agreement. This amendment also confirms the actions related to a merger with MindWave remain in effect.